Table: begin end state 1 11 cytoplasmic 12 33 transmembrane 34 37 non-cytoplasmic 38 67 transmembrane 68 86 cytoplasmic 87 107 transmembrane 108 126 non-cytoplasmic 127 150 transmembrane 151 167 cytoplasmic 168 191 transmembrane 192 202 non-cytoplasmic 203 225 transmembrane 226 245 cytoplasmic 246 268 transmembrane 269 273 non-cytoplasmic 274 292 transmembrane 293 303 cytoplasmic 304 325 transmembrane 326 344 non-cytoplasmic 345 363 transmembrane 364 365 cytoplasmic 366 385 transmembrane 386 389 non-cytoplasmic 390 414 transmembrane 415 431 cytoplasmic 432 453 transmembrane 454 459 non-cytoplasmic
Input: >WP_086509096.1 NCBI__GCF_002151265.1:WP_086509096.1 MARLSVMRWHKPIVTPTLSALAVLGCVILAVMGHYLSFLFFSLFTMLVLGMPIAISLAGS CLLFVLISGQVPDIVVAHRMINGIDSFPLLAIPFFIFAGSLMNNAGITERIFNFAKALMG WMRGGLGHVNVGASIVFSGMSGAAVADAGGLGMIEVKAMKDAGYDEEFAVGITAASSTIG PIIPPSLPMVIYGVMASASVGQLFAAGLLPGLLMGVMLMVMIFFIARRRGYQRDTTFSLR VLGHTFGRAVLSLMTPVIIVGGIITGAFTPTEAAVAAVFYALFLGVVVYRTLTWRKLIKV SMETIETTAVILFIVAAASIFAWILTSNQVTQHVIALMGPFSDSKVVVLMMTNLVLIIVG CFMETIAAITILVPVLLPLAVAVGVDPVHFGVIMVLNLMIGLLTPPVGMVLYVLSRVSNV SFERCMRGTIPFLIPLVLCLLLVTFVPAISMWLPTLVYR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server